XML 53 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash Flows from Operating Activities:    
Net income $ 147,745 $ 156,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 51,227 43,610
Amortization on marketable securities, net 967  
Impairment charge 8,212  
Provision for uncollectible accounts 1,808 1,678
Benefit of deferred income taxes (4,649) (6,729)
Share-based compensation expense 14,760 13,463
Other (305) (79)
Tax benefit from share-based compensation arrangements (10,044) (9,581)
Changes in assets and liabilities:    
Accounts receivable (51,024) (8,464)
Inventories (27,238) (12,638)
Other assets 41,041 (3,375)
Accounts payable (2,841) 6,876
Accrued liabilities (24,503) 16,216
Deferred revenue (2,688) 11,566
Net cash provided by operating activities 142,468 208,543
Cash Flows from Investing Activities:    
Purchases of property and equipment (67,517) (42,504)
Purchase of marketable securities (231,387)  
Proceeds from the sale and maturities of marketable securities 24,711  
Proceeds from sale of equity investment   5,400
Acquisitions of a businesses, net of cash acquired (8,200) (7,516)
Acquisition of intangible asset   (175)
Net cash used by investing activities (282,393) (44,795)
Cash Flows from Financing Activities:    
(Repayments) borrowings on revolving credit facilities, net (6,500) 98,000
Debt issue costs (199) (1,357)
Issuance of long term debt 250,097 200,000
Payment of notes payable   (1,394)
Repurchases of common stock (309,057) (468,968)
Proceeds from exercises of stock options and employee stock purchase plans 19,221 18,361
Tax benefit from share-based compensation arrangements 10,044 9,581
Net cash used by financing activities (36,394) (145,777)
Net effect of changes in exchange rates on cash (5,067) (4,294)
Net (decrease) increase in cash and cash equivalents (181,386) 13,677
Cash and cash equivalents at beginning of period 322,536 279,058
Cash and cash equivalents at end of period $ 141,150 $ 292,735